Article
Lung cancer patients who used statins in the year prior to a lung cancer diagnosis or after a lung cancer diagnosis had a reduction in the risk of death from the disease.
Lung cancer patients who used statins in the year prior to a lung cancer diagnosis or after a lung cancer diagnosis had a reduction in the risk of death from the disease, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
“Our study provides some evidence that lung cancer patients who used statins had a reduction in the risk of death from lung cancer,” said Chris Cardwell, PhD, a senior lecturer in medical statistics at the Centre for Public Health at Queen’s University Belfast in Northern Ireland.
Read more at the American Association for Cancer Research: http://bit.ly/1JGqxee
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
Incorporating Discussions of Cannabis Use Into Oncology Care Visits
From Policy to Practice: NCCN Summit Explores Equity in the Cancer Workforce